HIV Clinical Research Unit Operated by the USF Health Division of Infectious Disease & International Medicine at Hillsborough County Health Department
Research that makes a difference.
Your Subtitle text
Opportunities for better medical treatment don’t just happen. These opportunities are created by
careful clinical research into investigational pharmaceutical therapies. At the HIV Clinical Research Unit, we create these opportunities for our patients every day. By combining our efforts with state of the art clinical facilities for HIV care at the Specialty Care Center (which includes a dental care program) our patients receive the highest quality care possible.
careful clinical research into investigational pharmaceutical therapies. At the HIV Clinical Research Unit, we create these opportunities for our patients every day. By combining our efforts with state of the art clinical facilities for HIV care at the Specialty Care Center (which includes a dental care program) our patients receive the highest quality care possible. We offer an exceptional study and trial environment with highly qualified staff and an excellent performance record.
For both patients and physicians, this provides access to innovative experimental therapies before they are widely available. We are committed to delivering the best medical treatment: it is our mission to serve and heal.
Charurut Somboonwit MD FACP
Associate Professor of Medicine, Division of Infectious Disease & International Medicine, University of South Florida
Director, Communicable Diseases, Hillsborough County Health Department
About Us
The Clinical Research Unit was established in 1995 by Dr. Jeffrey Nadler through a partnership with University of South Florida. We
accept unfunded patients, Medicare, Medicaid, Hillsborough Heathcare and many commercial plans.Our patients gain:
- Early access to new drugs & lab tests
- More intensive disease management
- Access to qualified & experienced doctors
- We take time to educate patients on advancements in HIV care
For the past 14 years, the Florida HIV Research Unit has assisted in 24 successful HIV clinical drug trials that are now commercially available on the market including the following: nucleoside/nucleotide reverse transcriptase inhibitors, non-nucleoside/non-nucleotide reverse transcriptase inhibitors, protease inhibitors, entry inhibitors, and integrase inhibitors.
